Attached files
| file | filename |
|---|---|
| 10-K - 10-K - ORAMED PHARMACEUTICALS INC. | zk1415787.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ORAMED PHARMACEUTICALS INC. | Financial_Report.xls |
| EX-3.2 - EXHIBIT 3.2 - ORAMED PHARMACEUTICALS INC. | exhibit_3-2.htm |
| EX-31.1 - EXHIBIT 31.1 - ORAMED PHARMACEUTICALS INC. | exhibit_31-1.htm |
| EX-10.3 - EXHIBIT 10.3 - ORAMED PHARMACEUTICALS INC. | exhibit_10-3.htm |
| EX-10.7 - EXHIBIT 10.7 - ORAMED PHARMACEUTICALS INC. | exhibit_10-7.htm |
| EX-32.2 - EXHIBIT 32.2 - ORAMED PHARMACEUTICALS INC. | exhibit_32-2.htm |
| EX-10.2 - EXHIBIT 10.2 - ORAMED PHARMACEUTICALS INC. | exhibit_10-2.htm |
| EX-10.29 - EXHIBIT 10.29 - ORAMED PHARMACEUTICALS INC. | exhibit_10-29.htm |
| EX-23.1 - EXHIBIT 23.1 - ORAMED PHARMACEUTICALS INC. | exhibit_23-1.htm |
| EX-10.5 - EXHIBIT 10.5 - ORAMED PHARMACEUTICALS INC. | exhibit_10-5.htm |
| EX-10.21 - EXHIBIT 10.21 - ORAMED PHARMACEUTICALS INC. | exhibit_10-21.htm |
| EX-31.2 - EXHIBIT 31.2 - ORAMED PHARMACEUTICALS INC. | exhibit_31-2.htm |
| EX-3.1 - EXHIBIT 3.1 - ORAMED PHARMACEUTICALS INC. | exhibit_3-1.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the annual report of Oramed Pharmaceuticals Inc., or the Company, on Form 10-K for the period ended August 31, 2014, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Nadav Kidron, President, Chief Executive Officer and a Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, that to my knowledge:
|
1.
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
|
||
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
||
|
Dated: November 13, 2014
|
/s/ Nadav Kidron
|
||
|
Nadav Kidron
President and Chief Executive Officer
|
|||